By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vaxart, Inc. 

600 Townsend Street
Suite 120E
San Francisco  California  94103  U.S.A.
Phone: 415-437-0132 Fax:




Company News
Vaxart, Inc. Appoints John Harland As Chief Financial Officer 5/8/2014 9:36:00 AM
Vaxart, Inc.’s Oral H1N1 Influenza Vaccine Generates Protective Immunity 1/9/2014 10:20:57 AM
Flu Vaccine Developer Vaxart, Inc. Snags $20 Million 8/7/2013 7:55:33 AM
Vaxart, Inc. Creates Effective Oral H7N9 Avian Influenza Vaccine in 20 Days 6/26/2013 9:43:04 AM
Vaxart, Inc.’s Groundbreaking Tablet Influenza Vaccine Generates Protective Antibody Levels in Humans 6/19/2013 9:47:53 AM
Vaxart, Inc. Begins First Oral Vaccine Clinical Trial 6/7/2011 11:14:11 AM
Vaxart, Inc. Raises $12.5 Million Series B 3/4/2010 7:43:56 AM
Vaxart, Inc. Awarded National Institutes of Health (NIH) Grant to Support Development of Orally-Delivered H5N1 Avian Influenza Vaccine 9/8/2009 10:31:03 AM
Vaxart, Inc. Begins Animal Testing of H1N1 Flu Vaccine Candidate 5/26/2009 8:51:35 AM
Vaxart, Inc. Demonstrates Efficacy of Oral Avian Flu Vaccine in Preclinical Studies 10/24/2008 8:16:22 AM